Moderna, Inc.
MRNA
$53.57
$1.863.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -826.00M | -200.00M | -825.00M | -971.00M | -1.12B |
| Total Depreciation and Amortization | 67.00M | 52.00M | 57.00M | 39.00M | 60.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.00M | 119.00M | 146.00M | 106.00M | 148.00M |
| Change in Net Operating Assets | 1.56B | -818.00M | -297.00M | -211.00M | 1.74B |
| Cash from Operations | 930.00M | -847.00M | -919.00M | -1.04B | 825.00M |
| Capital Expenditure | -39.00M | -33.00M | -3.00M | -117.00M | -522.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -9.00M | 733.00M | 567.00M | 847.00M | -17.00M |
| Cash from Investing | -48.00M | 700.00M | 564.00M | 730.00M | -539.00M |
| Total Debt Issued | 600.00M | -- | -2.00M | 2.00M | -4.00M |
| Total Debt Repaid | -12.00M | -3.00M | -3.00M | -- | -10.00M |
| Issuance of Common Stock | 16.00M | 2.00M | 14.00M | 3.00M | 11.00M |
| Repurchase of Common Stock | -1.00M | 0.00 | 0.00 | -1.00M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.00M | -- | -- | -- | -- |
| Cash from Financing | 581.00M | -1.00M | 9.00M | 4.00M | -3.00M |
| Foreign Exchange rate Adjustments | 0.00 | 1.00M | 1.00M | -- | -1.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.46B | -147.00M | -345.00M | -303.00M | 282.00M |